Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
- PMID: 32348790
- PMCID: PMC7195041
- DOI: 10.1016/j.jhep.2020.04.027
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
Conflict of interest statement
Conflicts of interest The authors disclose no conflicts. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'.J Hepatol. 2020 Sep;73(3):722. doi: 10.1016/j.jhep.2020.05.005. Epub 2020 May 11. J Hepatol. 2020. PMID: 32437831 Free PMC article. No abstract available.
-
Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?J Hepatol. 2021 Feb;74(2):487-488. doi: 10.1016/j.jhep.2020.05.051. Epub 2020 Jun 20. J Hepatol. 2021. PMID: 32574578 Free PMC article. No abstract available.
Comment on
-
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278005 Free PMC article. No abstract available.
References
-
- Younossi Z.M. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70:531–544. - PubMed
-
- Gao F., Zheng K.I., Wang X.B., Sun Q.F., Pan K.H., Wang T.Y. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 2020 10.2337/dc20-0682. - PubMed
-
- Eslam M., Sanyal A.J., George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999–2014.e1. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources